Last Updated: October 20, 2026

Details for Patent: 7,014,867

Name: Drug Patent Intelligence for US Patent 7014867
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,014,867

Title:	Tablet comprising cetirizine and pseudoephedrine
Abstract:	The present invention concerns a tablet comprising two distinct segments. More particularly, the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
Inventor(s):	Domenico Fanara, Anthony Guichaux, Monique Berwaer, Michel Deleers
Assignee:	UCB SA
Application Number:	US10/481,264
Patent Claim Types: see list of patent claims	Composition; Compound; Dosage form;

Drugs Protected by US Patent 7,014,867

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,014,867

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	01115807	Jun 28, 2001

PCT Information
PCT Filed	June 10, 2002	PCT Application Number:	PCT/EP02/06342
PCT Publication Date:	January 09, 2003	PCT Publication Number:	WO03/002098

International Family Members for US Patent 7,014,867

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	034866	⤷ Start Trial
Austria	432068	⤷ Start Trial
Australia	2002345024	⤷ Start Trial
Bulgaria	108452	⤷ Start Trial
Bulgaria	66269	⤷ Start Trial
Brazil	0210650	⤷ Start Trial
Canada	2451519	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.